Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Genes Dev ; 28(13): 1429-44, 2014 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-24990963

RESUMEN

The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can hydroxylate FOXO3a on two specific prolyl residues in vitro and in vivo. Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a. FOXO transcription factors can repress Cyclin D1 transcription. Failure to hydroxylate FOXO3a promotes its accumulation in cells, which in turn suppresses Cyclin D1 expression. These findings provide new insights into post-transcriptional control of FOXO3a and provide a new avenue for pharmacologically altering Cyclin D1 activity.


Asunto(s)
Factores de Transcripción Forkhead/metabolismo , Regulación Neoplásica de la Expresión Génica , Prolina Dioxigenasas del Factor Inducible por Hipoxia/metabolismo , Ubiquitina Tiolesterasa/metabolismo , Animales , Línea Celular , Células Cultivadas , Ciclina D1/genética , Proteína Forkhead Box O3 , Hidroxilación , Células MCF-7 , Ratones , Unión Proteica , Estabilidad Proteica
2.
Nat Methods ; 5(3): 227-9, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18264106

RESUMEN

We developed a cell division-activated Cre-lox system for stochastic recombination of loxP-flanked loci in mice. Cre activation by frameshift reversion is modulated by DNA mismatch-repair status and occurs in individual cells surrounded by normal tissue, mimicking spontaneous cancer-causing mutations. This system should be particularly useful for delineating pathways of neoplasia, and determining the developmental and aging consequences of specific gene alterations.


Asunto(s)
Adenosina Trifosfatasas/genética , Reparación de la Incompatibilidad de ADN , Enzimas Reparadoras del ADN/genética , Proteínas de Unión al ADN/genética , Modelos Animales de Enfermedad , Integrasas/genética , Envejecimiento/genética , Animales , Mutación del Sistema de Lectura , Genes ras/genética , Intestinos/enzimología , Ratones , Endonucleasa PMS2 de Reparación del Emparejamiento Incorrecto , Neoplasias/etiología , Neoplasias/genética , Recombinación Genética , beta-Galactosidasa/genética
3.
Am J Pathol ; 164(4): 1447-53, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15039232

RESUMEN

A pretumor progression model predicts many oncogenic cancer mutations may first accumulate in normal appearing colon. Although direct observations of early pretumor mutations are impractical, it may be possible to retrospectively reconstruct tumor histories from contemporary cancer mutations. To infer when and in what order mutations occur during occult pretumor progression, we examined 14 cancers from individuals with heterozygous germline mutations in DNA mismatch repair (MMR) genes or hereditary nonpolyposis colorectal cancer (HNPCC). Somatic inactivation of the normal allele occurs sometime during a lifetime and results in loss of MMR, elevated mutation rates, and subsequent widespread somatic microsatellite mutations in HNPCC cancers. Patient ages at MMR loss can be estimated because intervals between MMR loss and cancer removal can be inferred from numbers of microsatellite tumor mutations. The relative order of MMR loss during pretumor progression may also be inferred from its collective ages of occurrence. Somatic MMR loss preceded cancer removal by an average of 6.1 years, occurred relatively late in life (average of 41.6 versus 47.7 years at cancer removal), and was a surprisingly late (fifth or sixth) step. Calculations indicate five or six oncogenic mutations could accumulate with relatively normal replication fidelity in normal appearing colon. HNPCC pretumor progression essentially begins from birth and ends with MMR loss, implying elevated mutation rates and tumorigenesis may be unnecessary for most progression.


Asunto(s)
Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Proteínas de Unión al ADN/genética , Proteínas de Neoplasias/genética , Lesiones Precancerosas/patología , Proteínas Proto-Oncogénicas/genética , Proteínas Adaptadoras Transductoras de Señales , Adulto , Factores de Edad , Disparidad de Par Base/genética , Proteínas Portadoras , Transformación Celular Neoplásica , Análisis Mutacional de ADN , Reparación del ADN/genética , Progresión de la Enfermedad , Mutación de Línea Germinal , Humanos , Repeticiones de Microsatélite/genética , Persona de Mediana Edad , Modelos Biológicos , Homólogo 1 de la Proteína MutL , Proteína 2 Homóloga a MutS , Proteínas Nucleares , Estudios Retrospectivos , Factores de Tiempo
4.
Carcinogenesis ; 23(11): 1807-10, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12419828

RESUMEN

Diet is an important risk factor for many cancers. High fat/low calcium (HFLC) diets are associated with increased tumorigenesis, whereas caloric restriction (CR) reproducibly increases lifespan and decreases tumors. Mutations are involved in aging and cancer, and different diets may alter mutagenesis. However, a number of repair pathways normally counteract mutations by correcting errors before they can be fixed in the genome. To further understand interactions between diet, aging and cancer, mice deficient in a major repair pathway called DNA mismatch repair (MMR) were fed HFLC, CR or control diets. Mlh1 deficient mice are prone to lymphomas and intestinal adenomas and carcinomas. No significant changes in adenocarcinoma or lymphoma incidence were observed with HFLC or CR diets. Significantly more (2.2-fold) adenomas occurred with HFLC diets although adenoma numbers were unchanged with CR. Only a small increase in lifespan (116% of control) was achieved with CR. In addition, levels of microsatellite mutations in the small and large intestines were unchanged with the different diets. Our studies indicate that MMR deficiency may be epistatic to certain otherwise strong environmental influences on carcinogenesis or aging.


Asunto(s)
Envejecimiento/genética , Disparidad de Par Base , Reparación del ADN , Dieta , Proteínas de Neoplasias/deficiencia , Neoplasias Experimentales/genética , Proteínas Adaptadoras Transductoras de Señales , Adenocarcinoma/etiología , Adenocarcinoma/genética , Adenocarcinoma/prevención & control , Adenoma/etiología , Adenoma/genética , Adenoma/prevención & control , Alimentación Animal/análisis , Animales , Calcio de la Dieta/administración & dosificación , Proteínas Portadoras , Dieta Reductora , Grasas de la Dieta/administración & dosificación , Grasas de la Dieta/toxicidad , Ingestión de Energía , Neoplasias Intestinales/etiología , Neoplasias Intestinales/genética , Neoplasias Intestinales/prevención & control , Longevidad , Linfoma/etiología , Linfoma/genética , Linfoma/prevención & control , Ratones , Ratones Noqueados , Homólogo 1 de la Proteína MutL , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/fisiología , Neoplasias Experimentales/etiología , Neoplasias Experimentales/prevención & control , Proteínas Nucleares
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA